about
YY1-binding sites provide central switch functions in the PARP-1 gene expression networkMuscle type-specific responses to NAD+ salvage biosynthesis promote muscle function in Caenorhabditis elegans.TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell deathSequence-motif detection of NAD(P)-binding proteins: discovery of a unique antibacterial drug target.Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseasesHelicobacter pylori activation of PARP-1: usurping a versatile regulator of host cellular healthInhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.p21CDKN1A Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates.Poly(ADP-ribose) polymerase 1 inhibition improves coronary arteriole function in type 2 diabetes mellitus.Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation.Inorganic pyrophosphatase defects lead to cell cycle arrest and autophagic cell death through NAD+ depletion in fermenting yeast.Differential regulation of cell death programs in males and females by Poly (ADP-Ribose) Polymerase-1 and 17β estradiolX-ray induced DNA damage and repair in germ cells of PARP1(-/-) male miceFrog (Pelophylax bergeri, Günther 1986) endocrine disruption assessment: characterization and role of skin poly(ADP-ribose) polymerases.Ex vivo protective effects of nicotinamide and 3-aminobenzamide on rat synaptosomes treated with Aβ(1-42).Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease.PARP inhibitor rucaparib induces changes in NAD levels in cells and liver tissues as assessed by MRS.Oxidative stress in female cancers.
P2860
Q21134068-5FCB9CBA-344E-4140-B7ED-64704B18A3B0Q30497873-93CF6D66-0A63-48CB-9CDC-42EB288AFBDFQ34037146-C4F7DDB8-28A8-47A9-8C4E-6071A5B3EDB3Q34241343-1DAA9938-668E-4248-A7F3-CE7E2A91523BQ34597741-C87D40D1-F854-4CF0-8F88-D290371C4EAFQ34664112-FB699987-951B-458A-840B-DC7B3412A8D2Q35856126-B46DBA97-AF05-4C1A-B316-E7089152D5DFQ35885207-69C68820-9987-4BBA-A6C0-60102378AE8CQ35903412-BD17D4E1-D835-4C08-A417-5647B6795C93Q36545177-8EDBBF8D-B3DB-490F-BC7D-2C06A0C83ED5Q36812488-0569EC49-9F94-428F-A977-B0C798921C73Q37148205-E0B240DA-C1A5-4D3F-B020-94D5F6CB554CQ37225093-497A413D-6881-4027-9CE9-6E271F3256C6Q46272600-E6CA6AC2-683A-4C56-8855-353AE5C0649CQ46853871-DE4B1FD0-FBDA-437A-BAF9-769054D9FEBBQ46979323-7DC86D7B-6949-4922-8B95-AA6CFF81A949Q50980480-339526AB-79EF-45B2-BB66-404371F0BB12Q55049874-87D84C33-D0C5-40DF-B103-8D77E10B8907
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Poly ADP-ribose polymerase-1 and health.
@en
Poly ADP-ribose polymerase-1 and health.
@nl
type
label
Poly ADP-ribose polymerase-1 and health.
@en
Poly ADP-ribose polymerase-1 and health.
@nl
prefLabel
Poly ADP-ribose polymerase-1 and health.
@en
Poly ADP-ribose polymerase-1 and health.
@nl
P2860
P356
P1476
Poly ADP-ribose polymerase-1 and health.
@en
P2093
James B Kirkland
P2860
P304
P356
10.1258/EBM.2010.009280
P577
2010-05-01T00:00:00Z